Changes in plasma norepinephrine, blood pressure and heart rate during physical activity in hypertensive man.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 541038)

Published in Hypertension on June 16, 1980

Authors

R D Watson, C A Hamilton, J L Reid, W A Littler

Articles by these authors

Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (1998) 8.75

Recommendations on blood pressure measurement. Br Med J (Clin Res Ed) (1986) 4.97

White-coat hypertension as a cause of cardiovascular dysfunction. Lancet (1996) 4.68

Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol (1973) 3.77

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet (1998) 3.41

Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ (2000) 3.37

Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol (2001) 3.18

Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13

Analysis of the pressor dose response. Clin Pharmacol Ther (1982) 2.44

Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation (1999) 2.42

Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers. Clin Pharmacol Ther (1981) 2.36

Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation (1996) 2.32

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J (1999) 2.23

Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 2.12

A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. Br J Clin Pharmacol (1982) 2.06

Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet (1983) 2.03

Proteinuria with streptokinase. Lancet (1993) 2.01

Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01

Topographic detection of photorefractive keratectomy. Ophthalmology (1998) 1.97

Patients with suspected myocardial infarction: effect of mode of referral on admission time to a coronary care unit. Br J Gen Pract (1992) 1.92

Coordinating and standardizing long-term care: evaluation of the west of Scotland shared-care scheme for hypertension. Br J Gen Pract (1994) 1.92

Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak. Q J Med (1979) 1.91

Continuous recording of direct arterial pressure and electrocardiogram in unrestricted man. Br Med J (1972) 1.91

Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91

Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. Br J Clin Pharmacol (1983) 1.89

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol (1982) 1.81

Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J (1983) 1.79

Renal pathological findings in infective endocarditis. Nephrol Dial Transplant (2000) 1.74

Emergency physicians. Accuracy in the diagnosis of stroke. Stroke (1995) 1.73

The Remler M2000 semi-automatic blood pressure recorder. Br Heart J (1979) 1.71

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69

Median nerve palsy--a complication of brachial artery cannulation. Postgrad Med J (1976) 1.65

Busulphan lung. Thorax (1969) 1.63

Cardiovascular reflexes in Parkinsonism. Clin Sci (1971) 1.62

Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. Br Med J (1971) 1.60

Acute aortitis and aortic incompetence due to systemic rheumatological disorders. Int J Cardiol (1991) 1.59

Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem (1997) 1.56

Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56

Direct arterial pressure, heart rate and electrocardiogram during human coitus. J Reprod Fertil (1974) 1.56

The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci (Lond) (1983) 1.56

Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation (2000) 1.54

Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability. Lancet (1979) 1.50

Some aspects of the arterial response to venous occlusion in man. Clin Sci (Lond) (1983) 1.49

Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. Clin Sci (Lond) (1985) 1.49

ABC of atrial fibrillation. Drugs for atrial fibrillation. BMJ (1995) 1.48

Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control. Clin Sci (Lond) (1999) 1.47

Verapamil pharmacokinetics and apparent hepatic and renal blood flow. Br J Clin Pharmacol (1985) 1.46

Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44

Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension (1999) 1.44

The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43

The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchongenic carcinoma. Br J Cancer (1975) 1.42

Identification of a novel antigen from Staphylococcus epidermidis. FEMS Immunol Med Microbiol (2000) 1.40

Left ventricular diastolic function in hypertensive patients with unstable angina and single coronary artery disease. Am J Hypertens (1995) 1.39

Dental prophylaxis for endocarditis. Lancet (1992) 1.39

A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction. J Intern Med (2000) 1.38

Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure. Circulation (1975) 1.37

Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut (1984) 1.36

Felodipine, blood pressure, and cardiovascular reflexes in hypertensive humans. Hypertension (1986) 1.36

The straight back syndrome. Q J Med (1980) 1.35

Felodipine in hypertension. Eur J Clin Pharmacol (1985) 1.32

Acute myocardial infarction in Asians and whites in Birmingham. Br Med J (Clin Res Ed) (1985) 1.32

Survival after acute myocardial infarction in Asian and white patients in Birmingham. Br Heart J (1995) 1.32

Technical report: quantitative assessment of diaphragmatic movement--a reproducible method using ultrasound. Clin Radiol (1992) 1.30

Desmethylimipramine and the hypotensive action of clonidine in the rabbit. Br J Pharmacol (1972) 1.30

Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man. J Hypertens (1985) 1.29

The effect of captopril on the reflex control heart rate: possible mechanisms. Br J Clin Pharmacol (1985) 1.29

Coronary artery disease in Asians in Birmingham. Br Heart J (1984) 1.29

Infections in 18,000 infants and children in a controlled study of respiratory tract disease. II. Variation in adenovirus infections by year and season. Am J Epidemiol (1972) 1.27

Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit. Br J Pharmacol (1973) 1.27

Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme. Heart (1999) 1.27

Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium. Cardiovasc Res (1980) 1.26

alpha 1-Adrenergic receptors in guinea pig myocardium: identification by binding of a new radioligand, (3H)-prazosin. Biochem Biophys Res Commun (1979) 1.26

Critical assessment of diagnostic value of endomyocardial biopsy. Assessment of cardiac biopsy. Br Heart J (1978) 1.26

Acquired pulmonary stenosis. Thorax (1970) 1.26

Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet (1989) 1.25

Eligibility for thrombolytic therapy in acute myocardial infarction. Lancet (1987) 1.25

Prazosin disposition in young and elderly subjects. Br J Clin Pharmacol (1981) 1.24

Why do patients develop reactions to streptokinase? Clin Exp Immunol (1993) 1.23

Physician variation in the management of patients with atrial fibrillation. Heart (1996) 1.23

A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man. Br J Clin Pharmacol (1987) 1.22

Evidence for postjunctional vascular alpha 2-adrenoceptors in peripheral vascular regulation in man. Clin Sci (Lond) (1983) 1.22

The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow. Br J Clin Pharmacol (1985) 1.20

The use of immunoadsorbent columns for the isolation of antibodies specific for antigens associated with human bronchogenic carcinoma. Br J Cancer (1974) 1.20

Idiopathic parkinsonism treated with bromocriptine. Lancet (1975) 1.20

Direct arterial pressure, heart rate, and electrocardiogram during cigarette smoking in unrestricted patients. Am Heart J (1975) 1.20

Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension. Br J Clin Pharmacol (1982) 1.19

Letter: Failure of "adequate" penicillin therapy to prevent bacterial endocarditis after tooth extraction. Lancet (1974) 1.19

Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab (1993) 1.18

Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet (1997) 1.18

Influence of racial origin on admission rates of patients with suspected myocardial infarction in Birmingham. Br Heart J (1991) 1.17

Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man. Clin Sci Mol Med (1977) 1.17

Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension (1995) 1.17

Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension. Eur J Clin Pharmacol (1977) 1.16

Preliminary experience with a hospital blood pressure follow up clinic with nurse practitioner assessment and microprocessor based data retrieval. Br Med J (Clin Res Ed) (1984) 1.16

Oral pharmacokinetics of omeprazole. Eur J Clin Pharmacol (1984) 1.16